OMEROS CORP cotiza a 19.63 USD y tiene una capitalización bursátil de $1.4B. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Omeros Corporation, a clinical-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting immunologic diseases. The company's lead products candidate is the Narsoplimab (OMS721/MASP-2) for the treatment of hematopoietic stem-cell tr…
| Periodo | 2026-11 | 2026-05 | 2026-03 | 2025-11 |
|---|---|---|---|---|
| Real | — | $0.57 | $3.14 | $-0.32 |
| Estimado | $-0.02 | $-0.39 | $2.24 | $-0.48 |
| Sorpresa | — | +246.2% | +40.2% | +33.3% |
| Métrica | OMER | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | — | -38.6% | — |
| Net Margin | — | -33.6% | — |
| FCF Margin | — | -13.9% | — |
| ROE | — | -40.4% | — |
| ROA | -1.0% | -32.0% | +31.0% |
| Current Ratio | 2.76 | 2.84 | -0.08 |
| Debt / Equity | -0.73 | 0.28 | -1.01 |